Sample Reports

Browse AI-powered formulation and simulation reports, including PK/PD product comparison reports, target-site exposure modeling, mechanism-level scoring, bioavailability, stability, nutraceutical, and cosmetic examples

Jump to PK/PD Product Comparisons Bioavailability Simulation Stability Simulation Target-Mechanism Simulation Nutraceutical Cosmetic

Simulation Reports

PBPK bioavailability, PK/PD product comparison, quantum chemistry stability simulations, and PD target-mechanism validation

PK/PD Product Comparison Simulations
Improved Cardio-Metabolic Formula vs Current Formula and a Market Comparator — PK/PD Comparison

Full-formula PK/PD simulation of a redesigned cardio-metabolic capsule at the same one capsule twice a day, in 100 virtual Asian adults aged 40–65. Against the current marketed formula (BeepActive beetroot-pomegranate extract with CoQ10) and a one-a-day blood-sugar capsule built on Reducose mulberry extract, the improved formula (Berbevis berberine, green coffee chlorogenic acid, pomegranate ellagic acid and resveratrol) leads on all 7 blood-sugar, lipid and blood-pressure mechanisms and all 4 customer outcomes, engaging them on average more than 6.5× as strongly as either product. Berbevis releases berberine gradually, holding it at active gut levels about 4× longer per dose than plain berberine at the same dose.

PK/PD Product Comparison Asian Adults 40–65 · n=100 Blood Sugar & Heart Health
Formulaite Metabolic Support vs Comparator — PK/PD Product Comparison

Combined PK/PD simulation comparing Formulaite Metabolic Support against a representative metabolic formula in an Asian adult overweight/obese virtual cohort. The model links target-site exposure, IC50/EC50 engagement, and docking de-risking to score mechanism-level support. Formulaite shows broader modeled coverage, including carb absorption support and GLP-1/GIP release & satiety signaling support.

PK/PD Product Comparison Asian Overweight/Obese Cohort Metabolic GLP-1/GIP Products
Choosing the Trial Population: Metabolic Product

Population simulation of a marketed polyherbal weight-management formula across 6 virtual cohorts (n=100 each), identifying which population to test it on before anyone is screened. Cohort choice moves trial size 1.8×: obese men 25–45 need 0.83× the participants of the reference cohort, obese adults 46–65 need 1.52×. Different endpoint, different cohort — obese men lead on blood sugar and liver fat, obese women on appetite. Recruitment cost is flagged too: the best population is harder to find, needing 15.3 people screened per participant against 1.5 for the reference.

PK/PD Trial Design 6 Cohorts · n=100 Each Marketed Polyherbal Formula
Bioavailability Simulations
Predicting Ingredient Synergy: A Marketed Women’s Libido Formula

PBPK simulation of fenugreek, shatavari and damiana extracts, alone and combined, in 100 virtual American women. The blend beats each extract alone: combined, Shatavarin IV bioavailability rises 1.70× and protodioscin 1.58×. One botanical boosts another — damiana’s apigenin is predicted to inhibit UGT1A1 and CYP3A4, the enzymes that break down both saponins. The biggest gains land where absorption is worst: the two saponins, under 1% bioavailable alone, gain the most, while better-absorbed trigonelline rises only 1.13×.

Bioavailability Ingredient Synergy n=100 · American Women 4 Formulations
Curcuminoid Formulations — ASD vs Phytosome vs Powder

Study-matched PBPK simulation predicts 54.2× higher dose-normalized bioavailability for hydrophilic carrier ASD versus crystalline powder, and 8.8× for phytosome. These results are close to Jäger et al. 2014 clinical benchmarks of 45.9× and 7.9×, respectively.

Bioavailability n=12 · Clinically Benchmarked
THC/CBD — Self-Nanoemulsifying Powder vs MCT Tincture

PBPK simulation validated against Hermush et al. 2025 — Capsoil self-nanoemulsifying powder achieves 2.28× THC and 2.26× CBD AUC vs MCT tincture control (clinical: 2.86×, 2.27×), with faster onset and 2.5× higher Cmax for THC, 2.7× for CBD from droplet-size–driven lipolysis and lymphatic uptake modeling.

Bioavailability n=100 · Clinically Benchmarked
Fenugreek + Shatavari — Menopausal PK

Population-level pharmacokinetics for seven bioactives across Fenugreek and Shatavari extracts, comparing general adults vs. menopausal Asian women (45–55y) with cross-extract DDI analysis.

Bioavailability n=100 · Menopausal
CBD / CBN — Gummies, Tinctures & Oral Strips

Cross-formulation PK comparison across 7 delivery formats at 25 mg dose. Buccal strips deliver 22-78% CBD (higher than sublingual) vs <2% for swallowed formats while fasted — a 40× gap. Food boosts oral formats 3-5× but barely matters for transmucosal routes. CBN outpaces CBD by 8-16% in transmucosal delivery but CBD outpaces CBN in oral delivery.

Bioavailability n=100 · US Pop.
Resveratrol — Buccal Strip vs Oral Powder

PBPK simulation across 100 virtual adults predicts 21.5% bioavailability for a 34 mg buccal strip versus 0.5% for a 2 g oral powder suspension—a 42× enhancement. Dose-normalized exposure at 2 hours is 13.3× higher, closely matching the approximately 15× clinical observation.

Bioavailability n=100 · US Pop.
Berberine — Capsule, Piperine & Buccal Strip

The "natural GLP-1" that barely survives digestion — PBPK simulation across 5 delivery arms reveals berberine's permanent positive charge blocks both food effects and buccal delivery, making piperine co-administration in a capsule a 2.8× boost and buccal strips a dose-constrained dead end.

Bioavailability n=100 · US Pop.
Kalmegh (Andrographis) Extract

PBPK quantification of the 2.9× bioenhancement from co-extracted flavonoids on andrographolide (10% → 29.2% F), showing that intrinsic extract synergy dominates over piperine's modest 1.05× additional lift.

Bioavailability n=100 · Asian Pop.

Formulation Reports

AI-powered R&D reports — evidence-based ingredient recommendations, regulatory compliance, and manufacturer-ready specifications

Nutraceutical
Ayurvedic Metabolic & Glycemic Support Capsule

A from-scratch Size 0 HPMC capsule for adults with diabetes and obesity, combining Fenugreek seed extract, Gymnema sylvestre, Bitter melon, Triphala, and Black pepper extract for GLP-1-like and GIP-like incretin support, glycemic regulation, weight management, and explicit muscle preservation.

Ayurvedic Capsule AYUSH 93 papers
Ayurvedic Multi-Pathway Metabolic Powder Sachet

A three-times-daily Ayurvedic powder sachet built from scratch for diabetes and obesity support, pairing Berberis aristata, Gymnema, Pterocarpus, Jamun, Bitter melon, Ceylon cinnamon, Curcuma, Ginger, Ashwagandha, Cissus, Coleus, and piperine for GLP-1-like and GIP-like activity, glucose control, weight management, and muscle preservation.

Ayurvedic Powder Sachet AYUSH 631 papers
Herbal Antidiabetic Capsule

A from-scratch herbal capsule formulation combining Berberine, Gymnema sylvestre, Zinc, Vitamin D3, and Chromium picolinate for comprehensive glycemic control, insulin resistance, and anti-obesity effects.

Herbal Capsule FSSAI · FDA 467 papers
Dabur Shilajit Gold Enhancement

Optimization of Dabur's Ayurvedic male vitality capsule, consolidating redundant ingredients and escalating Ashwagandha, Mucuna pruriens, and Yasada Bhasma to clinically-validated doses with Maricha piperine as a Yogavahi bioenhancer.

Ayurvedic Capsule AYUSH 80 papers
Liver Disease Restoration

An Ayurvedic hepatoprotective capsule enhancing Picrorhiza kurroa and Phyllanthus amarus with Andrographis paniculata, targeting liver enzyme restoration, lipid peroxidation suppression, and hepatocyte regeneration.

Ayurvedic Capsule AYUSH 114 papers